Neoplasms, Glandular and Epithelial

Showing 1 - 25 of 26

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Respiratory Tract Diseases, Tumors, Tumors by Histologic Type Trial run by the National Cancer Institute (NCI) (Bevacizumab)

Not yet recruiting
  • Respiratory Tract Diseases
  • +14 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 10, 2023

Carcinoma, Ovarian Epithelial, Ovarian Tumors, Fallopian Tube Tumors Trial in Iowa City (AB-1015)

Recruiting
  • Carcinoma, Ovarian Epithelial
  • +8 more
  • AB-1015
  • Iowa City, Iowa
    U. of Iowa Health Care
Jan 30, 2023

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Glioma, Recurrence, Disease Attributes Trial (Vorasidenib)

Available
  • Glioma
  • +10 more
  • (no location specified)
Oct 19, 2022

Parathyroid Diseases, Parathyroid Dysfunction, Parathyroid Tumors Trial in San Francisco (Parathyroid Eye (PTeye))

Active, not recruiting
  • Parathyroid Diseases
  • +9 more
  • Parathyroid Eye (PTeye)
  • San Francisco, California
    University of California, San Francisco
Jul 27, 2022

Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)

Completed
  • Carcinoma
  • +12 more
  • Ocoxin-Viusid
  • Havana, Cuba
    National Institute of Oncology and Radiobiology (INOR)
Jul 5, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Placebo)

Completed
  • Neoplasms
  • +14 more
  • San Antonio, Texas
    The START Center for Cancer Care
Apr 21, 2022

Overall Survival in Unresectable Hepatocellular Carcinoma

Completed
  • Carcinoma, Hepatocellular
  • +3 more
  • Osaka, Japan
  • +1 more
Mar 7, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)

Completed
  • Neoplasms
  • +13 more
  • San Antonio, Texas
    The START Center for Cancer Care
Jan 24, 2022

Carcinoma, Hepatocellular, Liver Tumors, Tumors, Glandular and Epithelial Trial in Nanning (Hepatic Resection, Radiofrequency

Recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hepatic Resection
  • Radiofrequency Ablation
  • Nanning, Guangxi, China
    Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
Jan 14, 2022

Oropharynx Cancer, Oropharynx Squamous Cell Carcinoma, Carcinoma, Squamous Cell Trial in Aarhus, Copenhagen, Odense (radiation,

Recruiting
  • Oropharynx Cancer
  • +18 more
  • Intensity-Modulated Radiation Therapy (IMRT)
  • +3 more
  • Aarhus, Denmark
  • +2 more
Sep 28, 2021

Uterine Cervical Tumors, Uterine Cervical Cancer, Tumors, Squamous Cell Trial in Seattle (BD SurePath Plus Pap test, BD SurePath

Terminated
  • Uterine Cervical Neoplasms
  • +6 more
  • BD SurePath Plus Pap test
  • +3 more
  • Seattle, Washington
    Seattle Women's: Health, Research, Gynecology
Apr 12, 2021

Ovarian Tumors, Fallopian Tube Tumors, Tumors by Site Trial (Drug: Anlotinib, Drug: Carboplatin/Paclitaxel)

Not yet recruiting
  • Ovarian Neoplasms
  • +14 more
  • Drug: Anlotinib
  • Drug: Carboplatin/Paclitaxel
  • (no location specified)
Mar 17, 2021

Ovarian Tumors, Fallopian Tube Tumors, Endocrine Gland Tumors Trial in Nanjing (Niraparib, Bevacizumab)

Unknown status
  • Ovarian Neoplasms
  • +23 more
  • Nanjing, Jiangsu, China
    JiangSu Cancer Hospital
Nov 8, 2020

Ovarian Cancer, Ovarian and Fallopian Tube Cysts and Tumors, Tumors by Site Trial in Nanjing (Anlotinib, Olaparib)

Recruiting
  • Ovarian Cancer
  • +18 more
  • Nanjing, Jangsu, China
    JiangSu Cancer Hospital
Oct 29, 2020

Ovarian Tumors, Carcinoma, Ovarian Epithelial, Tumor of Stomach Trial (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Ovarian Neoplasms
  • +7 more
  • (no location specified)
Aug 17, 2020

Prostatic Diseases, Genital Tumors, Male, Urogenital Tumors Trial in Los Angeles (Ixabepilone)

Terminated
  • Prostatic Diseases
  • +7 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
Oct 22, 2018

Low Rectal Cancer Study (MERCURY II)

Unknown status
  • Adenocarcinoma
  • +15 more
    • Berlin, Germany
    • +16 more
    Sep 17, 2018

    Adenocarcinoma of the Rectum, Adenocarcinoma, Adenocarcinoma, Mucinous Trial in Worldwide (Patients who have surgery at 12 weeks

    Unknown status
    • Adenocarcinoma of the Rectum
    • +16 more
    • Patients who have surgery at 12 weeks after radiotherapy/chemoradiotherapy
    • Sao Paulo, Brazil
    • +22 more
    Sep 14, 2018

    Molecular, Pathologic and MRI Investigation of Prognostic and

    Unknown status
    • Adenocarcinoma
    • +15 more
      • Peterborough, Cambridgeshire, United Kingdom
      • +18 more
      Sep 13, 2018

      Colorectal Tumors, Colonic Polyp, Adenoma Trial in United Kingdom (Endocuff Vision)

      Completed
      • Colorectal Neoplasms
      • +13 more
      • Endocuff Vision
      • South Shields, Tyne And Wear, United Kingdom
      • +15 more
      Sep 5, 2018

      Tumors, Glandular and Epithelial Trial in Tbilisi, Moscow, Yaroslav (VB6-845)

      Terminated
      • Neoplasms, Glandular and Epithelial
      • Tbilisi, Georgia
      • +5 more
      Dec 22, 2015

      Tumors, Glandular and Epithelial, Diphtheria, Tetanus Trial (Comparator: Quadrivalent Human Papillomavirus (HPV) vaccine,

      Completed
      • Neoplasms, Glandular and Epithelial
      • +4 more
      • Comparator: Quadrivalent Human Papillomavirus (HPV) vaccine
      • +4 more
      • (no location specified)
      Feb 23, 2015

      Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent, Carcinoma, Hepatocellular Trial in Worldwide

      Terminated
      • Hepatocellular Carcinoma Non-resectable
      • +12 more
      • Beverly Hills, California
      • +162 more
      Sep 7, 2012